Halper Sadeh Investigates Generation Bio's $4.29 Sale to XOMA for Shareholder Fairness
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 16 2025
0mins
Source: Businesswire
- Acquisition Fairness Investigation: Halper Sadeh LLC is investigating whether the sale of Generation Bio Co. to XOMA Royalty Corporation for $4.2913 per share is fair to shareholders, raising concerns about legal rights and options available to them.
- Board Accountability Review: The investigation focuses on whether Generation Bio's board violated federal securities laws and fiduciary duties by failing to secure the best possible deal for shareholders, potentially jeopardizing their interests.
- Insufficient Disclosure: Halper Sadeh highlights that Generation Bio may not have disclosed all material information necessary for shareholders to adequately assess and value the merger consideration, impacting their decision-making capabilities.
- Potential Remedies: Representing Generation Bio shareholders, Halper Sadeh may seek increased consideration for shareholders, additional disclosures, and other relief measures to safeguard their legal rights and interests.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
